| CTRI Number |
CTRI/2024/04/065536 [Registered on: 10/04/2024] Trial Registered Prospectively |
| Last Modified On: |
21/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
A Study to Understand the Usefulness of Cotyledon umbilicus in reducing the pain of sciatica prescribed according to the symptoms given in The Encyclopedia of Pure Materia Medica |
|
Scientific Title of Study
|
Open Label Prospective Clinical Study to Assess the Efficacy of
Cotyledon umbilicus Prescribed According to “The Encyclopedia
of Pure Materia Medica†for Managing the Pain of Sciatica |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Shayantan Kumar Das |
| Designation |
PG Scholar |
| Affiliation |
Dr MPK Homoeopathic Medical College Hospital and Research Centre |
| Address |
Department Of Materia Medica
Dr MPK Homoeopathic Medical College Hospital and Research Centre A Constituent College of Homoeopathy University Plot no 10,11,12 Saipura Sanganer Jaipur
Jaipur RAJASTHAN 302029 India |
| Phone |
9163680740 |
| Fax |
|
| Email |
shayantandas@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vanija Sharma |
| Designation |
Associate Professor and Head of the Department of Materia Medica |
| Affiliation |
Dr MPK Homoeopathic Medical College Hospital and Research Centre |
| Address |
Department Of Materia Medica
Dr MPK Homoeopathic Medical College Hospital and Research Centre A Constituent College of Homoeopathy University Plot no 10,11,12 Saipura Sanganer Jaipur
Jaipur RAJASTHAN 302029 India |
| Phone |
9680438770 |
| Fax |
|
| Email |
drvanijasharma@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Shayantan Kumar Das |
| Designation |
PG Scholar |
| Affiliation |
Dr MPK Homoeopathic Medical College Hospital and Research Centre |
| Address |
Department Of Materia Medica
Dr MPK Homoeopathic Medical College Hospital and Research Centre A Constituent College of Homoeopathy University Plot no 10,11,12 Saipura Sanganer Jaipur
Jaipur RAJASTHAN 302029 India |
| Phone |
9163680740 |
| Fax |
|
| Email |
shayantandas@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department Of Materia Medica Dr Girendra Pal Homoeopathic Hospital and Research Centre A Collegiate Hospital of Dr MPK Homoeopathic Medical College Hospital and Research Centre A Constituent College of Homoeopathy University Saipura Sanganer Jaipur 302029 |
|
|
Primary Sponsor
|
| Name |
Dr MPK Homoeopathic Medical College, Hospital and Research Centre |
| Address |
Plot no 10,11,12 Saipura Sanganer Jaipur
Pincode 302029 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shayantan Kumar Das |
Dr Girendra Pal Homoeopathic Hospital and Research Centre |
Department of Materia Medica, Room no 4, Unit 1, Dr MPK Homoeopathic Medical College, Hospital and Research Centre, Homoeopathy University, Plot no 10,11,12 Saipura Sanganer Jaipur
Pincode 302029 Jaipur RAJASTHAN |
9163680740
shayantandas@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Homoeopathy University Jaipur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M543||Sciatica, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Cotyledon umbilicus |
Oral administration of Cotyledon umbilicus in 30C two globules of size 40, dose and repetition - TDS and will be followed after 15 days or as per need of the case. Higher potency 200C and 1M of Cotyledon umbilicus will be given orally in form of globules size 40, dose and repetition – one dose followed by placebo two globules TDS for 15 days or as per need of the case. |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
25.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.Patient giving consent for the study.
2.Patient having minimum 3 symptoms of the following of Cotyledon umbilicus mentioned in “The Encyclopedia of Pure Materia Medica†by T. F. Allen as follows:
✓ Aching bruised pain all over the lower limbs. She can scarcely walk for aching in the limbs, legs feel heavy and sore.
✓ Pain and stiffness of the right hip, going off after a walk, in the evening. Shooting pain, sudden and sharp, in the right infra gluteal region, felt principally on walking in the open air.
✓ Great aching of the hip joint, relieved by moving about. Continual soreness of the hip and thigh, posteriorly.
✓ Aching in the left thigh, posteriorly. Aching in the back part of the left thigh, with numbness. Stringing pain under the left gluteal maximus, in the region of great sciatic nerve
3.Diagnosed cases taking treatment from other system of medicine having no relief seeking homoeopathic treatment.
4.Undiagnosed cases will be enrolled after confirming the following criteria: -
✓ Straight Leg Raise (SLR) positive.
✓ Patient presenting with clinical features of pain radiating down the back to the extremities with positive result of one or more neurological examination indicating nerve root tension or neurological deficit and numbness of the limbs.
✓ Xray of Lumbosacral Region (PA and Lateral View). |
|
| ExclusionCriteria |
| Details |
1.Females those are pregnant or lactating.
2.Patient refusing or not willing to give consent for the study.
3.Patient suffering from severe systemic diseases.
4.Cases requiring emergency/surgical intervention.
5.Patient from other pharmacological intervention and are not willing to leave it. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Improvement of the score obtained (pre and post treatment) from Modified Roland Morris Disability scale. |
Pre score will be taken at the baseline of treatment and post scores will be assessed at the end of 3 months using Modified Roland Morris Disability Scale. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To assess the efficacy of Cotyledon umbilicus in alleviating pain of sciatica prescribed according to the symptoms mentioned in "The Encyclopedia of Pure Materia Medica" and enlist additional symptoms verified during the study. |
12 months |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
22/04/2024 |
| Date of Study Completion (India) |
21/04/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is a prospective, non-randomized, open-label, single arm, unicentric, interventional clinical study to assess the efficacy of Cotyledon umbilicus in alleviating the pain of sciatica prescribed according to the symptoms mentioned in "The Encyclopedia of Pure Materia Medica". The study will evaluate the extend of improvement in pain due to sciatica using Modified Roland Morris Disability Scale as an assessment scale and to enlist additional symptoms verified during the study. The primary outcome will be according to the scores obtained (pre and post treatment) from the Modified Roland Morris Disability Scale. The secondary outcome will be assessing the efficacy of Cotyledon umbilicus in alleviating the pain of sciatica according to the symptoms mentioned in The Encyclopedia of Pure Materia Medica and enlisting additional symptoms verified during the study. NULL HYPOTHESIS (H0) – There will be no significant improvement in pain in the cases
of sciatica after prescribing Cotyledon umbilicus based on symptoms mentioned in “The
Encyclopedia of Pure Materia Medica†by T. F. Allen. ALTERNATIVE HYPOTHESIS (H1) – There will be significant improvement in pain in
the cases of sciatica after prescribing Cotyledon umbilicus based on symptoms mentioned in
“The Encyclopedia of Pure Materia Medica†by T. F. Allen. |